Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $75.45 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $30.15 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $29.13 | 2 | $0 (2017) |
| ViiV Healthcare Company | $16.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $30.15 | 2 | Gilead Sciences, Inc. ($30.15) |
| 2017 | $45.30 | 3 | Merck Sharp & Dohme Corporation ($29.13) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 02/20/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.24 | General |
| 05/17/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/03/2017 | ViiV Healthcare Company | TRIUMEQ (Drug), TIVICAY | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 36 | 74 | $21,165 | $6,123 |
| 2022 | 2 | 48 | 77 | $23,420 | $7,036 |
| 2021 | 3 | 104 | 225 | $57,610 | $17,883 |
| 2020 | 3 | 138 | 287 | $78,906 | $22,921 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 55 | $12,045 | $3,521 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $9,120 | $2,602 | 28.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $13,032 | $3,921 | 30.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 53 | $10,388 | $3,115 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 55 | 175 | $33,250 | $10,251 | 30.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 38 | $20,064 | $6,299 | 31.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $4,296 | $1,332 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 84 | 228 | $47,196 | $13,740 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 41 | 46 | $26,588 | $7,669 | 28.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 13 | $5,122 | $1,512 | 29.5% |
About Dr. Galant Chan, MD
Dr. Galant Chan, MD is a Internal Medicine healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942451422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Galant Chan, MD has received a total of $75.45 in payments from pharmaceutical and medical device companies, with $30.15 received in 2018. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($75.45).
As a Medicare-enrolled provider, Chan has provided services to 326 Medicare beneficiaries, totaling 663 services with total Medicare billing of $53,963. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Seattle, WA
- Active Since 10/02/2008
- Last Updated 07/16/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942451422
Products in Payments
- TRIUMEQ (Drug) $16.17
- ZERBAXA (Drug) $15.34
- CUBICIN RF (Drug) $13.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Seattle
Dr. Gust Bardy, M.d, M.D
Internal Medicine — Payments: $138.3M
Dr. Peter Shalit, M.d, M.D
Internal Medicine — Payments: $3.5M
Dr. Stanford Peng, Md, Phd, Facp, MD, PHD, FACP
Internal Medicine — Payments: $2.5M
Lawrence Fong, Md, MD
Internal Medicine — Payments: $693,314
Dr. Fengting Yan, Md, Phd, MD, PHD
Internal Medicine — Payments: $669,828
Dr. Scott Ramsey, M.d, M.D
Internal Medicine — Payments: $262,526